Conmed Closes Acquisition of Medical Device Maker In2Bones Global.

MANews-(C)2009-2022

US-based Conmed Corp. (NYSE: CNMD) has completed the acquisition of privately-held US-based medical device maker In2Bones Global Inc, the company said.

Headquartered in Memphis, Tennessee, In2Bones is a global developer, manufacturer, and distributor of medical devices for the treatment of disorders and injuries of the upper (hand, wrist, elbow) and lower (foot and ankle) extremities.

The company's product portfolio includes implants, fracture systems, biologics, and related hardware.

The transaction is being financed through a combination of the net proceeds of the company's 2.25% convertible notes, which were issued on June 6, 2022, borrowings under the company's amended and resaid credit facility, and cash on hand.

The company will provide additional guidance regarding the impact of the transaction on 2022 financial results when it reports second quarter...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT